Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
May 24, 2000

Morton Grove Pharmaceuticals Recalls Phosphate Topical Solution

Morton Grove, IL (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Morton Grove Pharmaceuticals is conducting a recall of Clindamycin Phosphate Topical Solution, USP, 1%, because of one degradant exceeded specification during stability testing.

The recalled Clindamycin Phosphate Topical Solution is packaged in 1-fluid ounce bottles - NDC #60432-693-30
and 2-fluid ounce bottles - NDC #60432-693-60.  This recall affects Lot Numbers: 21796 and 22334.

FDA stated in its report that over 8,000 bottles were distributed nationwide.  The firm estimated that less than 20 percent of the product remained.

This ongoing Class III recall was initiated by the company, by letter dated April 7, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-341-0

Notice of this product warning was sent via email to SafeMail subscribers May 24, 2000.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.